Champions Oncology, Inc.
CSBR
$6.88
$0.081.20%
NASDAQ
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -133.21% | -1,583.49% | 277.67% | 135.15% | 151.17% |
| Total Depreciation and Amortization | -20.27% | -13.79% | -17.26% | -17.56% | 0.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.63% | -45.25% | -31.92% | -77.73% | -44.33% |
| Change in Net Operating Assets | 110.33% | 339.45% | -1,411.20% | -185.75% | 29.28% |
| Cash from Operations | 92.93% | 478.19% | 153.32% | -148.05% | 107.79% |
| Capital Expenditure | -- | -8,533.33% | 54.35% | -18.99% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -8,533.33% | 54.35% | -18.99% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.70% | 0.00% | -11.76% | 50.00% | -- |
| Issuance of Common Stock | -- | 500.00% | -- | 15.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 62.16% | 13.51% | 100.00% | 78.36% | 93.73% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 97.08% | 455.84% | 142.87% | -121.43% | 105.22% |